We also observed a correlation between the expression levels of ADSL and the MYC oncogene, whose expression has been shown to be indirectly regulated by ADSL in triple-negative breast cancer 6 and whose upregulation of target genes is a signature of the CMS2 subtype 37. The gene discussed is MYC; the disease is triple-negative breast carcinoma.